PD-1 has been demonstrated to be expressed by a wide range of human cancers, including ovarian neoplasms, bladder carcinoma, head and neck squamous cell carcinoma, lung carcinoma, renal cell carcinoma (RCC), melanoma, and gastrointestinal cancers (135). Here, PDCD1 is linked to lung carcinoma.